- Home
- GNS vs CLNN Comparison
GNS vs CLNN Comparison
Compare GNS & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- CLNN
- Stock Information
- Founded
- GNS 2002
- CLNN 2012
- Country
- GNS Singapore
- CLNN United States
- Employees
- GNS N/A
- CLNN N/A
- Industry
- GNS Other Consumer Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- GNS Real Estate
- CLNN Health Care
- Exchange
- GNS Nasdaq
- CLNN Nasdaq
- Market Cap
- GNS 36.1M
- CLNN 37.7M
- IPO Year
- GNS 2022
- CLNN N/A
- Fundamental
- Price
- GNS $0.42
- CLNN $4.43
- Analyst Decision
- GNS
- CLNN Strong Buy
- Analyst Count
- GNS 0
- CLNN 4
- Target Price
- GNS N/A
- CLNN $55.25
- AVG Volume (30 Days)
- GNS 5.7M
- CLNN 47.6K
- Earning Date
- GNS 12-27-2024
- CLNN 03-12-2025
- Dividend Yield
- GNS N/A
- CLNN N/A
- EPS Growth
- GNS N/A
- CLNN N/A
- EPS
- GNS N/A
- CLNN N/A
- Revenue
- GNS $16,147,348.00
- CLNN $421,000.00
- Revenue This Year
- GNS $39.87
- CLNN N/A
- Revenue Next Year
- GNS $32.96
- CLNN N/A
- P/E Ratio
- GNS N/A
- CLNN N/A
- Revenue Growth
- GNS N/A
- CLNN N/A
- 52 Week Low
- GNS $0.32
- CLNN $3.82
- 52 Week High
- GNS $6.97
- CLNN $10.40
- Technical
- Relative Strength Index (RSI)
- GNS 40.37
- CLNN 42.58
- Support Level
- GNS $0.42
- CLNN $4.15
- Resistance Level
- GNS $0.54
- CLNN $4.99
- Average True Range (ATR)
- GNS 0.06
- CLNN 0.28
- MACD
- GNS 0.01
- CLNN 0.00
- Stochastic Oscillator
- GNS 44.44
- CLNN 33.33
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).